https://www.sifact.it/wp-content/uploads/2020/01/Annotazione-2020-01-26-184836.jpg
245
607
Marina Festinese
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
Marina Festinese2020-09-09 12:01:412020-09-09 12:05:21Bollettino SIFACT Insight Settembre 2020
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
0
0
Marina Festinese
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
Marina Festinese2020-07-17 07:35:592020-07-17 15:55:23CAR‐T treatment: Determining the progression‐free survival gain in patients with heavily pretreated multiple myeloma
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
0
0
Marina Festinese
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
Marina Festinese2020-07-17 07:30:462020-07-17 15:58:27Axicabtagene ciloleucel in non-Hodgkin lymphoma: the restricted mean survival time as a tool for estimating progression-free life expectancy better than the median
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
0
0
Marina Festinese
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
Marina Festinese2020-07-17 07:23:162020-07-17 16:02:29Omega-3 for the prevention of cardiovascular diseases: meta-analysis and trial-sequential analysis
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
0
0
Marina Festinese
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
Marina Festinese2020-07-17 07:14:212020-07-17 16:05:03CAR-T Treatment: Determining the Survival Gain in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
https://www.sifact.it/wp-content/uploads/2020/02/Pg-Bandi.jpg
200
800
Marina Festinese
https://www.sifact.it/wp-content/uploads/2019/12/logo_sifact_0-300x111.png
Marina Festinese2020-07-09 13:09:152020-07-09 13:10:47AVVISO PER L’ACQUISIZIONE DI CANDIDATURE PER UN INCARICO DI COLLABORAZIONE TECNICO SCIENTIFICA NEL CAMPO DELLA FARMACIA CLINICA
WEBINAR – Dalla genetica alle terapie personalizzate nelle malattie neurodegenerative: approfondimenti su Sclerosi Multipla e Atrofia Muscolare Spinale